Invivyd (IVVD) EBIT Margin (2024 - 2026)
Invivyd's (IVVD) quarterly EBIT Margin came in at 320.76% in Q2 2026, down 19298.0% on a YoY basis from N/an in Q2 2025, and down 339.61% quarter-over-quarter from 72.96% in Q4 2025.
Powered by 
Analysis
Invivyd (IVVD) EBIT Margin (2024 - 2026) Analysis & Trends
Invivyd (IVVD) has reported EBIT Margin for 3 consecutive years, with 320.76% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBIT Margin fell 19298.0% year-over-year to 320.76%; the trailing twelve-month figure through Jun 2026 stood at 149.73% (up 9594.0% YoY), and the FY2025 full-year result was 103.99%, up 59281.0% from the prior year.
- EBIT Margin eased to 320.76% in Q2 2026 per IVVD's latest filing, from 72.96% in the prior quarter.
- Across five years, EBIT Margin topped out at 72.96% in Q4 2025 and bottomed at 2175.22% in Q2 2024.
- Historically, EBIT Margin has averaged 467.44% across 3 years, with a median of 144.42% in 2024.
- The sharpest annual moves came in 2025 and 2026: EBIT Margin soared 204744 bps in 2025, then plunged 19298 bps in 2026.
- Over 3 years, EBIT Margin stood at 139.14% in 2024, then soared by 48 bps to 72.96% in 2025, then sank by 340 bps to 320.76% in 2026.
- According to Business Quant data, EBIT Margin over the past three periods registered 320.76%, 72.96%, and 83.96% for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 34.95% |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -133.21% |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 37.40% |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 30.15% |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 32.54% |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -562.07% |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 17.93% |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | -23.56% |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | -0.36% |
| 10 | Invivyd | 244.65 Mn | 84.57 Mn | 13.01 Mn | -320.76% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -320.76% |
| Dec 31, 2025 | -72.96% |
| Sep 30, 2025 | -83.96% |
| Jun 30, 2025 | -127.78% |
| Mar 31, 2025 | -149.70% |
| Dec 31, 2024 | -139.14% |
| Sep 30, 2024 | -670.01% |
| Jun 30, 2024 | -2,175.22% |